Aquestive Therapeutics
Warren
About Aquestive Therapeutics
Aquestive Therapeutics is a specialty pharmaceutical company that advances and commercializes medicines to solve critical healthcare problems and meaningfully improve people’s lives. Aquestive is committed to addressing immediate CNS challenges by furthering its strong pipeline of products. As the undisputed leader in developing and delivering drugs via its proprietary technologies, the Company also collaborates with pharmaceutical partners to bring new molecules to market in differentiated and highly-marketable dosage forms.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $50K – $100K
- Total funding: $453.1M
- Funding stage: IPO
- Last round: Post-IPO Equity (Aug 2025)
- Ticker: nasdaq:AQST
- Website: aquestive.com
- Phone: 908-941-1900
Industries & Categories
Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/aquestive-therapeutics-37841 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.